Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 5, 1996, Pages 855-868

  Lopez, Pedro F ^a,d   Sippy, Brian D ^a   Michael Lambert, H ^c   Thach, Allen B ^b   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

^c CULLEN EYE INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

Age related macular degeneration (ARMD); Choroidal neovascularization (CNV); Retinal pigment epithelium (RPE); Transdifferentiated; Vascular endothelial growth factor (VEGF)

Indexed keywords

ALPHA ACTIN; CYTOKERATIN; VASCULOTROPIN;

AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STROMA CELL; SUBRETINAL NEOVASCULARIZATION;

ACTINS; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; CHOROID; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LYMPHOKINES; MACULAR DEGENERATION; MALE; NEOVASCULARIZATION, PATHOLOGIC; PIGMENT EPITHELIUM OF EYE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029879849     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (107)

1. Lopez PF, Grossniklaus HE, Lambert HM, et al. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1991;112:647-656.
2. Grossniklaus HE, Martinez JA, Brown VB, et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;114:464-472.
3. Das A, Puklin JE, Frank RN, Zhang NL. Ultrastructural immunocytochemistry of subretinal neovascular membranes in age-related macular degeneration. Ophthalmology. 1992;99:1368-1376.
4. Hutchinson AK, Grossniklaus HE, Capone A. Giant-cell reaction in surgically excised subretinal neovascular membrane. Arch Ophthalmol 1993;111:734-735.
5. Lopez PF, Lambert HM, Grossniklaus HE, Sternberg PS Jr. Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration. Ophthalmology. 1993;100:415-422.
6. Grossniklaus HE. Clinicopathologic features of submacular neovascularization. Ophthalmol Clin North Am. 1993;6:359-374.
7. Grossniklaus HE, Hutchinson AK, Capone A Jr, Woolfson J, Lambert HM. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology. 1994;101:1094-1111.
8. Bynoe LA, Chang TS, Funata M, Del Priore LV, Kaplan HJ, Green, WR. Histopathologic examination of vascular patterns in subfoveal neovascular membranes. Ophthalmology. 1994;101:1112-1117.
9. Seregard S, Algvere PV, Berglin L. Immunohistochemical characterization of surgically removed subfoveal fibrovascular membranes. Graefes Arch Clin Exp Ophthalmol. 1994;232:325-329.
10. Hsu JK, Thomas MA, Ibanez H, Green WR. Clinicopathologic studies of an eye after submacular membranectomy for choroidal neovascularization. Retina. 1995;15:43-52.
11. Amin R, Pulkin JE, Frank RN. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994;35:3178-3188.
12. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: I: General concepts and classification. Am J Ophthalmol. 1967;63:573-585.
13. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium: III: Senile disciform macular degeneration. Am J Ophthalmol. 1967;63:617-644.
14. Green WR, Key SN. Senile macular degeneration: A histopathologic study. Trans Am Ophthalmol Soc. 1977;75:180-254.
15. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology. 1985;92:615-627.
16. Lopez PF, Green WR. Peripapillary subretinal vascularization: A review. Retina. 1992;12:147-171.
17. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
18. Heriot WJ, Henkind P, Belhorn RW, Burns MS. Choroidal neovascularization can digest Bruch's membrane: A prior break is not essential. Ophthalmology. 1984;91:1603-1608.
19. Crocker DJ, Murad TM, Geer JC. Role of the pericyte in wound healing: An ultrastructural study. Exp Mol Pathol. 1970;13:51-65.
20. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986;27:1644-1652.
21. Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci. 1990;31:899-908.
22. Glaser BM. Extracellular modulating factors and the control of intraocular neovascularization: An overview. Arch Ophthalmol. 1988;106:603-607.
23. Klagsburn M, D'Amore PA. Regulators of angiogenesis. Ann Rev Physiol. 1991;53:217-239.
24. Schultz GS, Grant MB. Neovascular growth factors. Eye. 1991;5:170-180.
25. D'Amore PA, Smith SR. Growth factor effects on cells of the vascular wall: Survey. Growth Factors. 1993;8:61-75.
26. Jampol LM, Ebroon DA, Goldbaum MH. Peripheral proliferative retinopathies: An update on angiogenesis, etiologies and management. Surv Ophthalmol. 1994;38:519-540.
27. Nehls V, Denzer K, Drenckhahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 1992;270:469-474.
28. Wallow IHL, Tso MOM. Repair after xenon arc photocoagulation: 2: A clinical and light microscopic study, the evolution of retinal lesions in the rhesus monkey. Am J Ophthalmol. 1973;75:610-626.
29. Wallow IHL, Tso MOM, Elgin S. Experimental photocoagulation of the human retina II. Electron microscopic study. Arch Ophthalmol. 1977;95:1041-1050.
30. Gillman T, Wright LJ. Autoradiographic evidence suggesting in vivo transformation of some blood mononuclears in repair and flbrosis. Nature. 1966;209:1086-1090.
31. Penfold PG, Provis JM, Bilson FA. Age-related macular degeneration: Ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefe's Arch Clin Exp Ophthalmol. 1987;225:70-76.
32. Tso MOM, Woodford BJ. Effect of photic injury on retinal tissues. Ophthalmology. 1983;90:952-963.
33. Turksen K, Opas M, Kalnins VI. Cytoskeleton, adhesion, and extracellular matrix of fetal human retinal pigmented epithelial cells in culture. Ophthalmic Res. 1989;21:56-66.
34. Hunt RC, Davis AA. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J Cell Physiol. 1990;145:187-199.
35. Vinores SA, Campochiaro PA, McGehee R, Orman W, Hackett SF, Hjelmeland LM. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia and fibroblasts in vitreous culture. Invest Ophthalmol Vis Sci. 1990;31:2529-2545.
36. Fuchs U, Kivelä T, Tarkkanen A. Cytoskeleton in normal and reactive human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991;32:3178-3186.
37. Robey HL, Hiscott PS, Grierson I. Cytokeratins and retinal epithelial cell behaviour. J Cell Sci. 1992;102:329-340.
38. Hiscott P, Gray R, Grierson I, Gregor Z. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol. 1994;78:219-222.
39. Grierson I, Hiscott P, Hogg P, Robey H, Mazure A, Larkin G. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8:255-262.
40. D'Amore PA. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev. 1990;9:227-238.
41. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858.
42. Plouët J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 1989;8:3801-3806.
43. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
44. Connolly DT, Olander JV, Heuvelman D, et al. Human vascular permeability factor. J Biol Chem. 1989;264:20017-20024.
45. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
46. Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun. 1989;165:1198-1206.
47. Conn G, Bayne ML, Soderman DD, et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA. 1990;87:2628-2632.
48. Dolecki GJ, Connolly DT. Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem Biophys Res Commun. 1991;180:572-578.
49. Favard C, Moukadiri H, Dorey C, Praloran V, Plouët J. Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell. 1991;73:1-6.
50. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. J Biol Chem. 1991;266:11947-11954.
51. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol. 1991;5:1806-1814.
52. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
53. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal epithelial cells. Biochem Biophys Res Commun. 1993;193:631-638.
54. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362:841-844.
55. Park JG, Keller GA, Ferrara NA. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993;4:1317-1326.
56. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
57. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112:1476-1482.
58. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
59. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. Eye. 1948;68:137-180.
60. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
61. Lambert HM, Capone A Jr, Aaberg TM, Sternberg PS Jr, Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1992;113:257-262.
62. Lambert HM, Lopez PF, Thomas JT. Surgical removal of submacular neovascular membranes in age-related macular degeneration. Ophthalmol Clin North Am. 1993;6:339-344.
63. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol. 1991;109:1242-1257.
64. Hudson HL, Frambach DA, Lopez PF. Relation of the functional and structural fundus changes after submacular surgery for neovascular age-related macular degeneration. Br J Ophthalmol. 1995;79:417-423.
65. Walshe R, Esser P, Wiedemann P, Heimann K. Proliferative retinal diseases: Myofibroblasts cause chronic vitreoretinal traction. Br J Ophthalmol. 1992;76:550-552.
66. Arora PD, McCulloch CAG. Dependence of collagen remodelling on α-smooth muscle actin expression by fibroblasts. J Cell Physiol. 1994;159:161-175.
67. Schmitt-Gräff A, Desmouliere A, Gabbiani G. Heterogeneity of myfibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchow's Arch. 1994;425:3-24.
68. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β-1 induces α smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-111.
69. Verbeek MM, Otte-Höller I, Wesseling P, Ruiter DJ, deWaal RM. Induction of α-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-β1. Am J Pathol. 1994;144:372-382.
70. Nehls V, Drenckhahn D. The versatility of microvascular pericytes: From mesenchyme to smooth muscle. Histochemistry. 1993;99:1-12.
71. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 1995;36:391-405.
72. Vidaurri-Leal JS, Glaser BM. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1376-1379.
73. Clarkson JG, Green WR, Massof D. A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol. 1977;84:1-17.
74. Kampik A, Kenyon KR, Michels RG, Green WR, De La Cruz Z. Epiretinal and vitreous membranes: Comparative study of 56 cases. Arch Ophthalmol. 1981;99:1445-1454.
75. Stern WH, Fisher SK, Anderson DH, et al. Epiretinal membrane formation after vitrectomy. Am J Ophthalmol. 1982;93:757-772.
76. Radtke ND, Tano Y, Chandler D, Machemer R. Simulation of massive periretinal proliferation by autotransplantation of retinal pigment epithelial cells in rabbits. Am J Ophthalmol 1981;91:76-87.
77. Machemer R, Laqua H. Pigment epithelial proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:1-23.
78. Laqua H, Machemer R. Clinical-pathological correlation in massive periretinal proliferation. Am J Ophthalmol. 1975;80:913-929.
79. Machemer R, Van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85:181-191.
80. Glaser BM, Cardin A, Biscoe B. Proliferative vitreoretinopathy: The mechanism of development of vitreoretinal traction. Ophthalmology. 1987;94:327-332.
81. Burgess D, Roper-Hall G, Burde RM. Binocular diplopia associated with subretinal neovascular membranes. Arch Ophthalmol. 1980;98:311-317.
82. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol. 1981;65:417-422.
83. Gass JDM. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol. 1984;68:513-519.
84. Krishan NR, Chandra SR, Stevens TS. Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol. 1985;100:698-707.
85. Yeo JH, Marius S, Murphy RP. Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology. 1988;95:8-13.
86. Toth CA, Pasquale AC III, Graichen DF. Clinicopathologic correlation of spontaneous retinal pigment epithelial tears with choroidal neovascular membranes in age-related macular degeneration. Ophthalmology. 1995;102:272-277.
87. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031-26037.
88. Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor, a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med. 1990;172:1535-1546.
89. Moukadiri H, Favard C, Bikfalvi A, Plouet J. Biosynthesis of vasculotropin and expression of vasculotropin receptors by cultured cells. In: Symposium on Biotechnology of Growth Factors. Lenfant C, Paoletti R, Albertini A, eds. Basel: Karger; 1991;123-128.
90. Guerrin M, Moukadiri H, Cholett P, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cellular Physiol. 1995;164:385-394.
91. Thieme H, Aiello LP, Takagi H, et al. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic endothelial cells. Diabetes. 1995;44:98-103.
92. Sakamoto T, Ishibashi T, Kimura H, et al. Effect of tecogalan sodium on angiogenesis hi vitro by choroidal endothelial cells. Invest Ophthalmol Vis Sci. 1995;36:1076-1083.
93. Hata Y, Nakagawa K, Ishibashi, Inomata H, Veno H. Hypoxia-induced expression of vascular endothelial growth factors by retinal glial cells promotes in vitro angiogenesis. Virchow's Arch. 1995;426:479-486.
94. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor vascular permeability factor. Cancer Res. 1990;1774-1778.
95. Pertovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem. 1994;269:6271-6274.
96. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblastic growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992;189:824-831.
97. Muthukristinan L, Warder E, McNeil PL. Basic fibres blast growth factor is efficiently released from cytosolic site through plasma membrane disruptions of endothelial cells. J Cell Physiol. 1991;148:1-16.
98. Vlodavsky I, Folkman J, Sullina R, et al. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into the subendothelial extracellular matrix. Proc Natl Acad Sci USA. 1987;84:2292-2296.
99. Keyt BA, Berleau L, Nguyen H, Henzel W, Ferrara N. Partial hydrolysis of vascular endothelial growth factor: Plasmin cleavage yields 110 amino acid bioactive form of VEGF. In: Program and Abstracts of the VIII International Symposium on the Biology of Vascular Cells. Heidelberg: 1995:48. Abstract.
100. Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 1993;133:829-837.
101. Klein R, Klein BE, Linton KLP. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
102. Aiello LP, Northrup JM, Key BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol. 1995;113:1538-1544.
103. Pe'er J, Sheweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
104. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial factor induced by hypoxia may mediate hypoxia-induced angiogenesis. Nature. 1992;39:843-845.
105. Plate KH, Breier G, Weich HA, Risiau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;39:845-848.
106. Zhao J, Frambach DA, Lee PP, Lopez PF. Delayed macular choriocapillary circulation in age-related macular degeneration. Int Ophthalmol. 1995;19:1-12.
107. Yannuzzi LA, Slakter JS, Sorensen JA, Guy DR, Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina. 1992;12:191-223.